Source: Annual Congress 2002 - Airway reactivity
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. P. Currie, S. J. Fowler, B. J. Lipworth (Dundee, United Kingdom). Dose-response of inhaled corticosteroids on bronchial hyperresponsiveness: a meta-analysis. Eur Respir J 2002; 20: Suppl. 38, 1923

Member's Comments

No comment yet.

Related content which might interest you: Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis Source: Eur Respir J 2004; 23: 552-558 Year: 2004 Effect of formoterol with or without budesonide in repeated low-dose allergen challenge Source: Eur Respir J 2009; 33: 747-753 Year: 2009 Changes in objective markers following inhaled corticosteroids (ICS) in asthmatics with airway hyperresponsiveness (AHR) to mannitol Source: International Congress 2019 – Airway physiology Year: 2019 Cost-minimisation analysis of two different inhaled steroids in persistent bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 302s Year: 2002 Refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation: is this phenomenon airway remodeling? Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Effects of inhaled corticosteroids on asthmatic inflammation: The FeNOtype trial Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Airway inflammation and inhaled corticosteroids in COPD Source: Eur Respir J, 49 (6) 1700289; 10.1183/13993003.00289-2017 Year: 2017 Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children Source: Eur Respir J 2011; 37: 800-805 Year: 2011 Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship Source: Eur Respir J 2002; 20: 601-608 Year: 2002 Sustained reduction of bronchial hyperresponsiveness with inhaled fluticasone propionate in mild asthma within three days Source: Eur Respir J 2002; 20: Suppl. 38, 197s Year: 2002 Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002 Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010 The effect of inhaled corticosteroids on airway hyperresponsiveness to mannitol in patients with Type 2 low asthma Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Comparative studies of inhaled corticosteroids in asthma Source: Eur Respir J 2001; 17: 579-580 Year: 2001 Protective effect of inhaled iloprost on specific bronchial challenge in aspirin-sensitive asthma Source: Eur Respir J 2002; 20: Suppl. 38, 471s Year: 2002 Zafirlucast influence on interleukin-2 in children with moderate bronchial asthma after cancellation of inhaled corticosteroids Source: Eur Respir J 2001; 18: Suppl. 33, 122s Year: 2001 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016 Year: 2017 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017 Year: 2017